Latest Healthcare News

Page 5 of 197
STERIS delivered 9% second-quarter revenue growth and lifted its fiscal 2027 adjusted EPS outlook, helped partly by tariff refunds. Life Sciences led the operating gains, while weaker cash flow and a new restructuring plan add important qualifications.
Ada Torres
Ada Torres
5 Nov 2026
HP has turned to former GSK chief Emma Walmsley to lead the company from January, handing her a compensation package featuring a US$30 million inducement equity award. Interim CEO Bruce Broussard will become chair as the company prepares a significant leadership reset.
Sophie Babbage
Sophie Babbage
5 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
McKesson delivered a strong fiscal second quarter, with revenue up 8% and adjusted diluted EPS rising 18%. The healthcare distributor lifted its full-year adjusted EPS guidance while expanding its specialty-care portfolio through new investments and acquisitions.
Ada Torres
Ada Torres
5 Nov 2026
CDW delivered a sharp third-quarter sales increase and lifted its quarterly dividend by about 8%, helped by demand for servers, storage, mobile devices and software. The stronger earnings picture came with lower gross margins, higher debt and weaker operating cash flow than a year earlier.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Charles River Laboratories delivered a second consecutive quarter of organic revenue growth and raised its 2026 outlook, despite reported revenue falling after divestitures. The quarter’s sharp GAAP earnings increase was heavily amplified by a US$245.6 million tax reserve reversal.
Ada Torres
Ada Torres
4 Nov 2026
Insulet delivered a stronger-than-expected third quarter, with revenue up 19.2% and adjusted earnings per share rising nearly 60%. The diabetes-device maker also raised its operating-margin outlook and authorised a US$1 billion share repurchase programme.
Ada Torres
Ada Torres
4 Nov 2026
Cencora delivered a stronger fiscal 2026, with adjusted earnings per share rising 12.3% and quarterly profit benefiting from the OneOncology acquisition. The healthcare distributor expects another 8% to 10% increase in adjusted EPS in fiscal 2027, while reshaping its reporting structure and lifting its dividend.
Ada Torres
Ada Torres
4 Nov 2026
CVS Health plans to separate its healthcare solutions and retail pharmacy businesses by the first half of 2028, while raising its 2026 earnings and cash-flow targets. The announcement came alongside stronger third-quarter results, though management flagged elevated cost trends and potential macroeconomic pressure.
Ada Torres
Ada Torres
4 Nov 2026
Zimmer Biomet lifted its full-year 2026 sales and adjusted earnings guidance after third-quarter constant-currency growth accelerated to 3.7%. The result was supported by strong hips, sports medicine and technology sales, although GAAP earnings fell and knees remained a weak spot.
Ada Torres
Ada Torres
4 Nov 2026
Amgen delivered 8% third-quarter revenue growth and a 19% increase in GAAP diluted EPS, while newer medicines continued to expand. The result came alongside sharp declines in Prolia and XGEVA sales from biosimilar competition and a busy pipeline of late-stage programmes.
Victor Sage
Victor Sage
4 Nov 2026
Revvity has lifted its full-year 2026 outlook after reporting stronger third-quarter revenue, organic growth and profitability. The life sciences and diagnostics group is also preparing to sell its China immunodiagnostics business for up to US$200 million.
Ada Torres
Ada Torres
4 Nov 2026

Browse the archive

Full archive